News
-
19.11.2017 Lorem ipsum dolor sit amet consectetuer
Adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.
-
19.11.2017 Lorem ipsum dolor sit amet consectetuer
Adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.
-
19.11.2017 Lorem ipsum dolor sit amet consectetuer
Adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.
Facts
-
Our Competencies
The network offers an attractive performance portfolio in the fields of
- Target identification & validation
- Drug discovery
- Medicinal chemistry
- Drug targeting & drug delivery
- Preclinical research
- Enabling technologies (…)
to potential customers, partners and investors for participation and cooperation.
-
Our Members
NetPhaSol is a German network of 47 partners (currently 27 companies and 20 scientific institutions), e.g. JPT Peptide Technologies (subsidiary of BioNTech AG) and 3B Pharmaceuticals.
Here you find here a detailed list of our members and their competence portfolios -
Your Benefits
Members of our network are supported in a targeted way in order to
- Submit promising applications for R&D projects
- Develop new products and technologies in joint projects
- Join forces in marketing and distribution
- Gain more market power and visibility
- Provide joint services and products for pharmaceutical industry